Browse > Article
http://dx.doi.org/10.4014/jmb.2107.07046

Antibacterial Effect of Chitosan-Modified Fe3O4 Nanozymes on Acinetobacter baumannii  

Wang, Wenjun (The First Affiliated Hospital of Guangzhou Medical University)
Wu, ziman (The First Affiliated Hospital of Guangzhou Medical University)
Shi, peiru (Guangzhou Medical University (KingMed school of Laboratory Medicine))
Wu, pinyun (Guangzhou Medical University (KingMed school of Laboratory Medicine))
Qin, peng (Guangzhou Medical University (KingMed school of Laboratory Medicine))
Yu, lin (The First Affiliated Hospital of Guangzhou Medical University)
Publication Information
Journal of Microbiology and Biotechnology / v.32, no.2, 2022 , pp. 263-267 More about this Journal
Abstract
The aim of this study was to determine whether the antibacterial activity of chitosan-modified Fe3O4 (CS@Fe3O4) nanomaterials against Acinetobacter baumannii (A. baumannii) is mediated through changes in biofilm formation and reactive oxygen species (ROS) production. For this purpose, the broth dilution method was used to examine the effect of CS@Fe3O4 nanoparticles on bacterial growth. The effects of CS@Fe3O4 nanoparticles on biofilm formation were measured using a semi-quantitative crystal violet staining assay. In addition, a bacterial ROS detection kit was used to detect the production of ROS in bacteria. The results showed that CS@Fe3O4 nanoparticles had a significant inhibitory effect on the colony growth and biofilm formation of drug-resistant A. baumannii (p < 0.05). The ROS stress assay revealed significantly higher ROS levels in A. baumannii subjected to CS@Fe3O4 nanoparticle treatment than the control group (p < 0.05). Thus, we demonstrated for the first time that CS@Fe3O4 nanoparticles had an inhibitory effect on A. baumannii in vitro, and that the antibacterial effect of CS@Fe3O4 nanoparticles on drug-resistant A. baumannii was more significant than on drug-sensitive bacteria. Our findings suggest that the antibacterial mechanism of CS@Fe3O4 nanoparticles is mediated through inhibition of biofilm formation in drug-resistant bacteria, as well as stimulation of A. baumannii to produce ROS. In summary, our data indicate that CS@Fe3O4 nanoparticles could be used to treat infections caused by drug-resistant A. baumannii.
Keywords
Nanozyme; antibacterial activity; Acinetobacter baumannii;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Takoi H, Fujita K, Hyodo H. 2019. Acinetobacter baumannii can be transferred from contaminated nitrile examination gloves to polypropylene plastic surfaces. Am. J. Infect. Control 47: 1171-1175   DOI
2 Yan BC, Cao J, Liu J, Gu Y, Xu Z, Li D, et al. 2021. Dietary Fe3O4 nanozymes prevent the injury of neurons and blood-brain barrier integrity from cerebral ischemic stroke. ACS Biomater. Sci. Eng. 7: 299-310.   DOI
3 Nikolova MP, Chaval MS. 2020. Metal oxide nanoparticles as biomedical materials. Biomimetics (Basel, Switzerland) 5: 1-47.
4 Yin YY, Wu MX, Q T, He KM, Xu N, Shi Y, et al. 2019. Effect of iron based nanoenzyme on Salmonella typhimurium biofilm. Prog. Biochem. Biophys. 46: 587-595.
5 Liu ZW, Wang FM, Ren JS, Qu XG. 2019. A series of MOF/Ce-based nanozymes with dual enzyme-like activity disrupting biofilms and hindering recolonization of bacteria. Biomaterials 208: 21-31.   DOI
6 Mazur P, Skiba-Kurek I, Mrowiec P, Karczewska E, Drod R. 2020. Synergistic ROS-associated antimicrobial activity of silver nanoparticles and gentamicin against. Int. J. Nanomedicine 15: 3551-3562.   DOI
7 Wang X, Wan R, Gu H, Fu GQ, Tang HQ, Hu GY. 2020. Well-water-dispersed N-trimethyl chitosan/Fe3O4 hybrid nanoparticles as peroxidase mimetics for quick and effective elimination of bacteria. J. Biomater. Sci. Polym. Ed. 31: 969-983.   DOI
8 Pourhajibagher M, Hosseini N, Boluki E, Chiniforush N, Bahador A. 2020. Photoelimination potential of chitosan nanoparticles-indocyanine green complex against the biological activities of strains: a preliminary study in burn wound infections. J. Lasers Med. Sci. 11: 187-192.   DOI
9 Rozman NAS, Tong WY, Leong CR, Tan WN, Hasanolbasori MA , Abdullah SZ. 2019. Potential antimicrobial applications of Chitosan Nanoparticles (ChNP). J. Microbiol. Biotechnol. 29: 1009-1013   DOI
10 Luo Y, Yang QQ, Zhang D, Yan W. 2021. Mechanisms and control strategies of antibiotic resistance in pathological biofilms. J. Microbiol. Biotechnol. 31: 1-7   DOI
11 Tian MD, Zhu CM, Luo C, Gong MJ, Bi Y. 2014. Cytotoxicity of superparamagnetic iron oxide nanoparticles modified by chitosan or sodium oleate. Acad. J. Second Mil. Med. Univ. 35: 366-371.   DOI
12 Mea HJ, Yong PVC, Wong EH. 2021. An overview of Acinetobacter baumannii pathogenesis: motility, adherence and biofilm formation. Microbiol. Res. 247: 126722.   DOI
13 Lee HS, Song HS, Lee HJ, Kim SH, Suh MJ, Cho JY, et al. 2021. Comparative study of the difference in behavior of the Accessory Gene Regulator (Agr) in USA300 and USA400 community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J. Microbiol. Biotechnol. 31: 1060-1068   DOI
14 Song YL, Liang X, Song X. 2018. The study on the inhibition of Shigella biofilm formation by the exopolysaccharides of Lactobacillus plantarum-12. Food Res. Devel. 39: 144-151.
15 Sarshar M, Behzadi P, Scribano D, Palamara AT, Ambrosi C. 2021. Acinetobacter baumannii: an ancient commensal with weapons of a pathogen. Pathogens 10: 387   DOI
16 Cha MH, Kim SH, Kim S, Lee W, Kwak HS, Chi YM, et al. 2021. Antimicrobial resistance profile of Acinetobacter spp. isolates from retail meat samples under campylobacter-selective conditions. J. Microbiol. Biotechnol. 31: 733-739   DOI
17 Pakharukova N, Tuittila M, Paavilainen S. 2018. Structural basis for Acinetobacter baumannii biofilm formation. Proc. Natl. Acad. Sci. USA 115: 5558-5563.   DOI
18 Wu J, Wang X, Wang Q, Lou SR, Li YY. 2018. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II). Chem. Soc. Rev. 48: 1004-1076.   DOI
19 Jiang D, Ni D, Rosenkrans ZT, Huang P, Yan XY, Cai WB. 2019. Nanozyme: new horizons for responsive biomedical applications. Chem. Soc. Rev. 48: 3683-3704   DOI
20 Xu JB, Xing YY, Liu YT, Liu MZ, Hou XH. 2021. Facile in situ microwave synthesis of Fe3O4@MIL-100(Fe) exhibiting enhanced dual enzyme mimetic activities for colorimetric glutathione sensing. Anal. Chim. Acta 1179: 338825.   DOI
21 Wang H, Joseph JA. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27: 612-616.   DOI
22 Wang H, Li P, Yu D, Yan Z, Qu X. 2018. Unraveling the enzymatic activity of oxygenated carbon nanotubes and their application in the treatment of bacterial infections. Nano Lett. 18: 3344-3351.   DOI
23 Evelhoch SR. 2020. Biofilm and chronic nonhealing wound infections. Surg. Clin. North Am. 100: 727-732.   DOI
24 Tang Y, Chou Y, Xu ZB, Gao LZ. 2018. Antibacterial mechanism and application of nano enzymes. Prog. Biochem. Biophys. 45: 118-128.
25 Tao L, Lemoff A, Wang G, Zarek C, Lowe A, Yan N, et al. 2020. Reactive oxygen species oxidize STING and suppress interferon production. Elife 9: e57837.   DOI
26 Gedefie A, Demsis W, Ashagrie M, Kassa Y, Tesfaye M, Tilahun M, et al. 2021. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect. Drug Resist. 14: 3711-3719.   DOI
27 Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. 2021. Acinetobacter baumannii antibiotic resistance mechanisms. Pathogens 10: 373   DOI
28 Saipriya K, Swathi CH, Ratnakar KS, Sritharan V. 2020. Quorum-sensing system in Acinetobacter baumannii: a potential target for new drug development. J. Appl. Microbiol. 128: 15-27.   DOI
29 Jiao J, Fan K, Hu Z, Yan X, Du P. 2019. Development trend and priority areas of nanozyme. Sci. Sin. Chim. 49: 1442-1453.
30 Shahini Shams Abadi M, Mirzaei E, Bazargani A, Gholipour A, Heidari H, Hadi N. 2020. Antibacterial activity and mechanism of action of chitosan nanofibers against toxigenic Clostridioides (Clostridium) difficile isolates. Ann. Ig. 32: 72-80.